This secondary analysis of the PETACC-3 trial examines the association of sex with incidence and severity of chemotherapy-related toxic effects in patients with stage II and III colorectal cancer treated with fluorouracil and leucovorin with or without irinotecan hydrochloride.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6145725 | PMC |
http://dx.doi.org/10.1001/jamaoncol.2018.1080 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!